Zengjun Li
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Hematology top 5%
- Multiple Myeloma Research and Treatments
Papers in
-
- Protein Degradation and Inhibitors 6
- Ubiquitin and proteasome pathways 5
-
- Lymphoma Diagnosis and Treatment 29
- Co-authors
- Yanlai Sun (20 shared papers)Jianjun Han (8 shared papers)Zhongfa Xu (9 shared papers)Dehui Zou (41 shared papers)Shuhua Yi (41 shared papers)Huirong Xu (6 shared papers)Lugui Qiu (45 shared papers)Yan Xu (26 shared papers)
- Journals
- Blood (16 papers)Oncotarget (7 papers)Journal of Clinical Oncology (6 papers)Frontiers in Immunology (3 papers)Therapeutics and Clinical Risk Management (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Zengjun Li
120 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 92
- Genetics 227
- Hematology 216
- Oncology 390
- Pathology and Forensic Medicine 245
- Cancer Research 206
Countries citing papers authored by Zengjun Li
This map shows the geographic impact of Zengjun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zengjun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zengjun Li more than expected).
Fields of papers citing papers by Zengjun Li
This network shows the impact of papers produced by Zengjun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zengjun Li. The network helps show where Zengjun Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Zengjun Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 133 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 100 | |
| 2 | 2020 | 94 | |
| 3 | 2016 | 62 | |
| 4 | 2016 | 56 | |
| 5 | 2014 | 55 | |
| 6 | 2014 | 50 | |
| 7 | 2015 | 46 | |
| 8 | 2016 | 45 | |
| 9 | 2011 | 39 | |
| 10 | 2010 | 39 | |
| 11 | 2011 | 32 | |
| 12 | 2015 | 26 | |
| 13 | 2017 | 25 | |
| 14 | 2012 | 25 | |
| 15 | 2021 | 23 | |
| 16 | 2016 | 23 | |
| 17 | 2021 | 22 | |
| 18 | 2015 | 22 | |
| 19 | 2015 | 22 | |
| 20 | 2017 | 18 |
About Zengjun Li
Zengjun Li is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Genetics, Oncology and Hematology, having authored 133 papers that have together received 1.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (30 papers), Lymphoma Diagnosis and Treatment (29 papers), Multiple Myeloma Research and Treatments (17 papers), CAR-T cell therapy research (9 papers), Protein Degradation and Inhibitors (6 papers), MicroRNA in disease regulation (6 papers), Ubiquitin and proteasome pathways (5 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Genetics (227 citations), Hematology (216 citations), Oncology (390 citations), Pathology and Forensic Medicine (245 citations) and Cancer Research (206 citations). Zengjun Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yanlai Sun, Jianjun Han, Zhongfa Xu, Dehui Zou, Shuhua Yi, Huirong Xu, Lugui Qiu, Yan Xu, Jianning Li and Shuhui Deng. Their work appears in journals such as Blood, Oncotarget, Journal of Clinical Oncology, Frontiers in Immunology and Therapeutics and Clinical Risk Management.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.